Relevant Market Insights India’s biopharmaceutical sector is at a pivotal point in its evolution. Long celebrated as the world’s “pharmacy of the world” for generics and vaccines, the broader bi...
In recent years, India’s pharmaceutical landscape has witnessed a significant transformation. Beyond being the “pharmacy of the world” for affordable medicines, India is emerging as a preferred global...
Relevant Global and Market Data India’s biopharmaceutical export story is one of remarkable transformation. From being a net importer of medicines in the late 20th century to becoming the “...
Latest Developments on API Self-Reliance India has long been recognized as the “pharmacy of the world,” supplying affordable generic medicines to countries across the globe. However, despite its...
Recent Industry Context Clinical trials have always been a crucial pillar of healthcare innovation, acting as the bridge between breakthrough science and real-world patient benefit. In recent ye...
Key Highlights: Implications: Oncology ace Vanneste turbocharges MSD’s immuno-oncology push against Roche/Pfizer, targeting India’s exploding cancer caseload with ke...
Key Highlights: Implications: Nubeqa’s India approval intensifies mHSPC competition against Janssen’s Erleada, amid prostate therapeutics market growing at 8.2% CAGR to $739M by 2030. ...
Key Highlights: Implications: Zydus’ smart-pen assault smashes generic pricing barriers, handing endocrinologists flexible dosing that trumps competitor pens while exploding Tier-2 a...
Key Highlights: Implications: Semaglutide generics could slash Novo Nordisk pricing by 70-80% in India’s $2.5B diabetes market (12% CAGR), capturing 25%+ share and pressuring chronic...
Key Highlights: Implication: This divestment signals multinational pharma firms accelerating exits from legacy India operations, potentially pressuring peers like Roche and Sanofi to restructure...
